Janux Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(19.99%),Peter Kolchinsky(19.99%)等
Janux Therapeutics | 4:持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.
Janux Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Jay Lichter, Ph.D.(17.1%),Tighe Reardon(10.4%)等
Janux Therapeutics | 4:持股變動聲明-股東 Avalon Ventures XI, L.P.
Janux Therapeutics | 4:持股變動聲明-董事 Gujrathi Sheila
Janux Therapeutics | 4:持股變動聲明-董事 CAPPS VICKIE L
Janux Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%)等
Janux Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Citadel Advisors LLC(6.8%),Citadel Advisors Holdings LP(6.8%)等
Janux Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-BVF Partners L.P.(9.9%),BVF Inc.(9.9%)等
Janux Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-David Campbell, Ph.D.(5.3%)
Janux Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(10.117%),Abigail P. Johnson(10.117%)
Janux Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Bregua Corporation(8.3%)
Janux Therapeutics | 4:持股變動聲明-高管 Winter Charles M.
Janux Therapeutics | 4:持股變動聲明-高管 Robinson Byron
Janux Therapeutics | 4:持股變動聲明-高管 Campbell David Alan
Janux Therapeutics | 4:持股變動聲明-高管 DiRaimondo Thomas
Janux Therapeutics | 4:持股變動聲明-高管 Reardon Tighe
Janux Therapeutics | 4:持股變動聲明-高管 Meyer Andrew Hollman
Janux Therapeutics | 3:首次持股聲明-高管 DiRaimondo Thomas
Janux Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Jay Lichter, Ph.D. (“Lichter”)(21.2%),Tighe Reardon (“Reardon”)(12.5%)等
暫無數據